Literature DB >> 21732711

Comparison of deposition in the USP and physical mouth-throat models with solid and liquid particles.

Yue Zhou1, Jaijie Sun, Yung-Sung Cheng.   

Abstract

BACKGROUND: Experimental deposition was studied using three different mouth-throat models: (1) the standard United States Pharmacopeia induction port (IP), (2) the idealized human mouth and throat replica developed by the University of Alberta (UofA replica), and (3) the conductive rubber mouth-throat cast from a human subject developed by Lovelace Respiratory Research Institute (LRRI cast).
METHODS: Both solid and liquid monodispersed fluorescent particles in the size range of 2-30 μm in diameter were delivered into the devices at flow rates of 15, 30, and 60 L min(-1). For solid particles, the study was conducted with and without grease coating inside the devices to investigate the effects of particle bounce.
CONCLUSIONS: Large amounts of rebounded particles were found for the IP and UofA replica without the coating treatment, while particle bounce was only observed at the large particle size for the LRRI cast. The UofA replica and LRRI cast agreed well for solid particles with coating treatments and liquid particles. The deposition results from this study were also compared to data of in vivo deposition studies from the literature. The deposition efficiencies in the UofA replica and LRRI cast were within the range of in vivo data, which showed a large scatter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732711      PMCID: PMC3229815          DOI: 10.1089/jamp.2011.0882

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  17 in total

1.  Mouthpiece diameter affects deposition efficiency in cast models of the human oral airways.

Authors:  T C Lin; P N Breysse; B L Laube; D L Swift
Journal:  J Aerosol Med       Date:  2001

2.  Mouth and oropharyngeal deposition of pharmaceutical aerosols.

Authors:  A R Clark; S P Newman; N Dasovich
Journal:  J Aerosol Med       Date:  1998

3.  An experimental method for measuring aerosol deposition efficiency in the human oral airway.

Authors:  K H Cheng; Y S Cheng; H C Yeh; D L Swift
Journal:  Am Ind Hyg Assoc J       Date:  1997-03

4.  The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract.

Authors:  M Lippmann; R E Albert
Journal:  Am Ind Hyg Assoc J       Date:  1969 May-Jun

5.  Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.

Authors:  Y S Cheng; C S Fu; D Yazzie; Y Zhou
Journal:  J Aerosol Med       Date:  2001

6.  Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.

Authors:  W Stahlhofen; J Gebhart; J Heyder
Journal:  Am Ind Hyg Assoc J       Date:  1980-06

7.  In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.

Authors:  W H DeHaan; W H Finlay
Journal:  J Aerosol Med       Date:  2001

Review 8.  Aerosol delivery through an artificial airway.

Authors:  Neil R MacIntyre
Journal:  Respir Care       Date:  2002-11       Impact factor: 2.258

9.  In vitro effect of a holding chamber on the mouth-throat deposition of QVAR (hydrofluoroalkane-beclomethasone dipropionate).

Authors:  Muhib F Rahmatalla; Peter C Zuberbuhler; Carlos F Lange; Warren H Finlay
Journal:  J Aerosol Med       Date:  2002

10.  Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans.

Authors:  T L Chan; M Lippmann
Journal:  Am Ind Hyg Assoc J       Date:  1980-06
View more
  7 in total

1.  De-agglomeration Effect of the US Pharmacopeia and Alberta Throats on Carrier-Based Powders in Commercial Inhalation Products.

Authors:  Sharon Shui Yee Leung; Patricia Tang; Qi Tony Zhou; Zhenbo Tong; Cassandra Leung; Janwit Decharaksa; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2015-07-23       Impact factor: 4.009

Review 2.  Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.

Authors:  Yung Sung Cheng
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

3.  Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.

Authors:  Conor A Ruzycki; Laleh Golshahi; Reinhard Vehring; Warren H Finlay
Journal:  Pharm Res       Date:  2014-01-07       Impact factor: 4.200

4.  Using Filters to Estimate Regional Lung Deposition with Dry Powder Inhalers.

Authors:  Scott Tavernini; Dino J Farina; Andrew R Martin; Warren H Finlay
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

5.  Lower Inspiratory Breathing Depth Enhances Pulmonary Delivery Efficiency of ProAir Sprays.

Authors:  Mohamed Talaat; Xiuhua April Si; Jinxiang Xi
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-03

6.  Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery.

Authors:  Ross L Walenga; Geng Tian; P Worth Longest
Journal:  J Biomech Eng       Date:  2013-09       Impact factor: 2.097

7.  Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate.

Authors:  Mellissa Gomez; Joseph McCollum; Hui Wang; Mani Ordoubadi; Chester Jar; Nicholas B Carrigy; David Barona; Isobel Tetreau; Michelle Archer; Alana Gerhardt; Chris Press; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Int J Pharm       Date:  2020-12-02       Impact factor: 5.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.